174 related articles for article (PubMed ID: 30514991)
1. Effect of Long-term Carbamazepine Therapy on Bone Health.
Suljic EM; Mehicevic A; Mahmutbegovic N
Med Arch; 2018 Oct; 72(4):262-266. PubMed ID: 30514991
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Mintzer S; Boppana P; Toguri J; DeSantis A
Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
[TBL] [Abstract][Full Text] [Related]
3. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
[TBL] [Abstract][Full Text] [Related]
4. Longterm Antiepileptic Therapy and Bone Health: Implications for Patients with Brain Tumors.
Mehičević A; Mahmutbegović N; Omerhodžić I; Mehmedika Suljić E
Acta Med Acad; 2020; 49 Suppl 1():23-29. PubMed ID: 33543627
[TBL] [Abstract][Full Text] [Related]
5. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
[TBL] [Abstract][Full Text] [Related]
6. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
Kim SH; Lee JW; Choi KG; Chung HW; Lee HW
Epilepsy Behav; 2007 Mar; 10(2):291-5. PubMed ID: 17224308
[TBL] [Abstract][Full Text] [Related]
7. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
Pack AM; Morrell MJ; Randall A; McMahon DJ; Shane E
Neurology; 2008 Apr; 70(18):1586-93. PubMed ID: 18443309
[TBL] [Abstract][Full Text] [Related]
8. Relationship between Bone Density and Biochemical Markers of Bone among Two Groups Taking Carbamazepine and Sodium Valproate for Epilepsy in Comparison with Healthy Individuals in Yazd.
Rahimdel A; Dehghan A; Moghadam MA; Ardekani AM
Electron Physician; 2016 Nov; 8(11):3257-3265. PubMed ID: 28070260
[TBL] [Abstract][Full Text] [Related]
9. Long-term anticonvulsant therapy leads to low bone mineral density--evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells.
Feldkamp J; Becker A; Witte OW; Scharff D; Scherbaum WA
Exp Clin Endocrinol Diabetes; 2000; 108(1):37-43. PubMed ID: 10768830
[TBL] [Abstract][Full Text] [Related]
10. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
Serin HM; Koç ZP; Temelli B; Esen İ
Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
[TBL] [Abstract][Full Text] [Related]
11. The effects of antiepileptic drugs on the relationships between leptin levels and bone turnover in prepubertal children with epilepsy.
Aksoy A; Sönmez FM; Deger O; Hosver I; Karagüzel G
J Pediatr Endocrinol Metab; 2011; 24(9-10):703-8. PubMed ID: 22145460
[TBL] [Abstract][Full Text] [Related]
12. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
Koo DL; Hwang KJ; Han SW; Kim JY; Joo EY; Shin WC; Lee HW; Seo DW; Hong SB
Epilepsy Res; 2014 Mar; 108(3):442-7. PubMed ID: 24507862
[TBL] [Abstract][Full Text] [Related]
13. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
14. [Effect of topiramate and carbamazepine on bone metabolism in children with epilepsy].
Zhang J; Wang KX; Wei Y; Xu MH; Su JM; Bao YG; Zhao SY
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Feb; 12(2):96-8. PubMed ID: 20199720
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of bone turnover in epileptic children using oxcarbazepine.
Cansu A; Yesilkaya E; Serdaroğlu A; Hirfanoğlu TL; Camurdan O; Gülbahar O; Gücüyener K; Cinaz P
Pediatr Neurol; 2008 Oct; 39(4):266-71. PubMed ID: 18805365
[TBL] [Abstract][Full Text] [Related]
17. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine.
Verrotti A; Greco R; Latini G; Morgese G; Chiarelli F
Epilepsia; 2002 Dec; 43(12):1488-92. PubMed ID: 12460249
[TBL] [Abstract][Full Text] [Related]
18. Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy.
Nettekoven S; Ströhle A; Trunz B; Wolters M; Hoffmann S; Horn R; Steinert M; Brabant G; Lichtinghagen R; Welkoborsky HJ; Tuxhorn I; Hahn A
Eur J Pediatr; 2008 Dec; 167(12):1369-77. PubMed ID: 18270736
[TBL] [Abstract][Full Text] [Related]
19. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years.
Kafali G; Erselcan T; Tanzer F
Clin Pediatr (Phila); 1999 Feb; 38(2):93-8. PubMed ID: 10047942
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
Chou IJ; Lin KL; Wang HS; Wang CJ
Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
